The Global 3D Printed Drugs Industry is expected to reach a valuation of US$ 742.88 Million by 2032, with the market expanding at a stellar CAGR of 9.2% from 2022 to 2032. The target market will likely generate an estimated US$ 307.54 Million by the end of 2022. Large-scale applications in the healthcare sector along with the …